DOI QR코드

DOI QR Code

Role of Methacholine PC20 in FEF25-75% for the Diagnosis of Bronchial Asthma

  • Son, Kyeong Min (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Jang, Seung Hun (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kang, Hye Ryun (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Han, Bo Ram (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Joo Hee (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Hyun Sung (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Park, Sung Hoon (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Hwang, Yong Il (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Kim, Dong Gyu (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine) ;
  • Jung, Ki Suck (Division of Pulmonary, Allergy, and Critical Care Medicine, Sacred Heart Hospital, Hallym University College of Medicine)
  • Received : 2009.08.03
  • Accepted : 2009.09.18
  • Published : 2009.10.30

Abstract

Background: The methacholine bronchial provocation test is a useful tool for evaluating asthma in patients with normal or near normal baseline lung function. However, the sensitivity of this test is 82~92% at most. The purpose of this study is to evaluate the clinical usefulness of $FEF_{25-75%}$ in identification of airway hyperresponsiveness in patients with suspected asthmatic symptoms. Methods: One hundred twenty-five patients who experienced cough and wheezing within one week prior to their visiting the clinic were enrolled. Results: Sixty-four subjects showed no significant reduction of $FEV_{1}$ or $FEF_{25-75%}$ on the methacholine bronchial provocation test (Group I). In 24 patients, $FEF_{25-75%}$ fell more than 20% from baseline without a 20% fall of $FEV_{1}$ during methacholine challenge (Group II). All patients who had more than 20% fall of $FEV_{1}$ (n=37) also showed more than 20% of reduction in $FEF_{25-75%}$ (Group III). Baseline $FEV_{1}$/FVC (%) and $FEF_{25-75%}$ (L) were higher in group II than group III (81.51${\pm}$1.56% vs. 75.02${\pm}$1.60%, p<0.001, 3.25${\pm}$0.21 L vs. 2.45${\pm}$0.21 L, p=0.013, respectively). Group II had greater reductions of both $FEV_{1}$ and $FEF_{25-75%}$ than group I at 25 mg/mL of methacholine (p<0.001). The provocative concentration of methacholine causing a 20% fall in $FEF_{25-75%}$ in group II was about three-fold higher than that in group III. Conclusion: A 20% fall of $FEF_{25-75%}$ by methacholine provocation can be more sensitive indicator for detecting a milder form of airway hyperresponsiveness than $FEV_{1}$ criteria.

Keywords

References

  1. Sistek D, Tschopp JM, Schindler C, Brutsche M, Ackermann-Liebrich U, Perruchoud AP, et al. Clinical diagnosis of current asthma: predictive value of respiratory symptoms in the SAPALDIA study. Swiss Study on Air Pollution and Lung Diseases in Adults. Eur Respir J 2001;17:214-9 https://doi.org/10.1183/09031936.01.17202140
  2. Cockcroft DW. Chapter 73. Bronchial challenge testing. In: Adkinson NF, Middleton E, editors. Middleton's allergy: principles & practice. 7th ed. Philadelphia: Mosby Elsevier; 2009. p. 1295-305
  3. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20 determination in a random selection of young college students. J Allergy Clin Immunol 1992;89:23-30 https://doi.org/10.1016/S0091-6749(05)80037-5
  4. Song HJ, Chung JW, Choi JH, Suh CH, Nahm DH, Park HS. Clinical significance of bronchial hyperresponsiveness to adenosine 5-monophosphate in bronchial asthma. J Asthma Allergy Clin Immunol 2004;24:299-304
  5. Lee BJ, Min TH, Choi DC. Ever wheeze as a predictor of cough variant asthma. J Asthma Allergy Clin Immunol 2004;24:94-102
  6. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7 https://doi.org/10.1016/0091-6749(75)90107-4
  7. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-29 https://doi.org/10.1164/ajrccm.161.1.ats11-99
  8. Cockcroft DW, Davis BE, Todd DC, Smycniuk AJ. Methacholine challenge: comparison of two methods. Chest 2005;127:839-44 https://doi.org/10.1378/chest.127.3.839
  9. Allen ND, Davis BE, Hurst TS, Cockcroft DW. Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. Chest 2005;128:4018-23 https://doi.org/10.1378/chest.128.6.4018
  10. Perpina M, Pellicer C, de Diego A, Compte L, Macian V. Diagnostic value of the bronchial provocation test with methacholine in asthma: a Bayesian analysis approach. Chest 1993;104:149-54 https://doi.org/10.1378/chest.104.1.149
  11. Marseglia GL, Cirillo I, Vizzaccaro A, Klersy C, Tosca MA, La Rosa M, et al. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis. Allergy Asthma Proc 2007;28:74-8 https://doi.org/10.2500/aap.2007.28.2920
  12. Simon MR, Havstad S, Cotronei C, Krell W, Johnson CC, Peterson EL. Assessment of mid flow rate measurements in patients undergoing methacholine challenge. Allergy Asthma Proc 2006;27:404-10 https://doi.org/10.2500/aap.2006.27.2903
  13. Lebecque P, Kiakulanda P, Coates AL. Spirometry in the asthmatic child: is FEF25-75 a more sensitive test than FEV1/FVC? Pediatr Pulmonol 1993;16:19-22 https://doi.org/10.1002/ppul.1950160105
  14. Rhee KH, Kim JK, Kim JH, Lim DH, Son BK. Usefulness of FEF25-75% in methacholine bronchial provocation test in children with asthma. Pediatr Allergy Respir Dis 2005;15:408-14
  15. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ. Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997;52:372-4 https://doi.org/10.1136/thx.52.4.372
  16. Sosa IP, Nanulescu M. Induced sputum--means for detecting bronchial inflammation in children with atopic bronchial asthma and treatment monitoring. Pneumologia 2004;53:79-84
  17. Louis R, Bettiol J, Cataldo D, Bureau F, Seumois G, Radermecker M, et al. Value of induced sputum in the investigation of asthma. Rev Mal Respir 2003;20:215-23
  18. Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy 2005;35:598-601 https://doi.org/10.1111/j.1365-2222.2005.02222.x
  19. Park SW, Lee YM, Jang AS, Lee JH, Hwangbo Y, Kim DJ, et al. Development of chronic airway obstruction in patients with eosinophilic bronchitis: a prospective follow-up study. Chest 2004;125:1998-2004 https://doi.org/10.1378/chest.125.6.1998

Cited by

  1. Misunderstandings and Truth about Chronic Cough vol.92, pp.6, 2009, https://doi.org/10.3904/kjm.2017.92.6.506
  2. Physiological tests of small airways function in diagnosing asthma: a systematic review vol.7, pp.1, 2009, https://doi.org/10.1136/bmjresp-2020-000770
  3. Analysis of PC20-FEF25%-75% and ΔFVC in the methacholine bronchial provocation test vol.9, pp.3, 2009, https://doi.org/10.4168/aard.2021.9.3.141